Treg cell therapy: How cell heterogeneity can make the difference
Open accessThe DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
CD4 + CD25 high CD127 low/− FOXP3 + T regulatory cells are responsible for maintaining immune tolerance and controlling excessive immune responses. Treg cell use in pre‐clinical animal models showed the huge therapeutic potential of these cells in immune‐mediated diseases and laid the foundations for their applications in therapy in humans. Currently, there are several clinical trials utilizing the adoptive transfer of Treg cells to reduce the morbidity in autoimmune disorders, allogeneic HSC transplantation, and solid organ transplantation. However, a large part of them utilizes total Treg cells without distinction of their biological variability. Many studies on the heterogeneity of Treg cell population revealed distinct subsets with different functions in the control of the immune response and induction of peripheral tolerance. Some of these subsets also showed a role in controlling the general homeostasis of non‐lymphoid tissues. All these Treg cell subsets and their peculiar properties can be therefore exploited to develop novel therapeutic approaches. This review describes these functionally distinct subsets, their phenotype, homing properties and functions in lymphoid and non‐lymphoid tissues. In addition, we also discuss the limitations in using Treg cells as a cellular therapy and the strategies to enhance their efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of nicotinic acetylcholine receptors on their surface promotes clonal expansion within the hippocampus and modulates neuroinflammation via acetylcholine signaling [33,34].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [33]
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Self-citation
Cited by
Recent advances in molecular mechanisms of skin wound healing and its treatments
Mamun, A. A., Shao, C., Geng, P., Wang, S., & Xiao, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395479 · Cited by 284
Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases
Tang, X., Ji, T.-T., Dong, J.-R., Feng, H., Chen, F.-Q., Chen, X., Zhao, H., Chen, D., & Ma, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313009 · Cited by 116
An ROS‐Scavenging Treg‐Recruiting Hydrogel Patch for Diabetic Wound Healing
Qu, M., Xu, W., Zhou, X., Tang, F., Chen, Q., Zhang, X., Bai, X., Li, Z., Jiang, X., & Chen, Q. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202314500 · Cited by 107
Sepsis-associated encephalopathy: From pathophysiology to clinical management
Hong, Y., Chen, P., Gao, J., Lin, Y., Chen, L., & Shang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110800 · Cited by 102
Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases
Ou, Q., Power, R., & Griffin, M. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287465 · Cited by 81
Schlöder, J., Shahneh, F. Z., Schneider, F.-J., & Wieschendorf, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.973813 · Cited by 67
Huang, J., Li, X., Zhu, Q., Wang, M., Xie, Z., & Zhao, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425847 · Cited by 66
Stability and plasticity of regulatory T cells in health and disease
Contreras-Castillo, E., García-Rasilla, V. Y., García-Patiño, M. G., & Licona-Limón, P. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae049 · Cited by 50
Chen, H., Li, Y., Wang, J., Zheng, T., Wu, C., Cui, M., Feng, Y., Ye, H., Dong, Z., & Dang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310828 · Cited by 52
“In addition, Treg cells can play an anti-inflammatory role in various immune diseases by secreting anti-inflammatory cytokines, including IL-10, and inhibiting immune cell activity [50,51].”
BackgroundWardell, C. M., MacDonald, K. N., Levings, M. K., & Cook, L. E. (2020) · European Journal of Immunology · doi:10.1002/eji.202048746 · Cited by 40
Cheng, Y., Li, L., Wei, X., Xu, F., Huang, X., Qi, F., Zhang, Y., & Li, X. (2023) · Cancer Science · doi:10.1111/cas.15745 · Cited by 39
Zhang, C., Li, Y., Yu, Y., Li, Z., Xu, X., Talifu, Z., Liu, W., Yang, D., Gao, F., Wei, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1334828 · Cited by 42
Hoffmann, A. D., Weinberg, S. E., Swaminathan, S., Chaudhuri, S. M., Almubarak, H. F., Schipma, M. J., Mao, C., Wang, X., El-Shennawy, L., Dashzeveg, N. K., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2023.109634 · Cited by 34
“single cell transcriptome analysis of the sorted Treg populations identified 10 distinct clusters, confirming that human circulating Treg populations are highly heterogenous regardless with or without microbial infection [12,19,39,40,52].”
Wang, Y., Chen, X., Huws, S., Xu, G., Li, J., Ren, J., Xu, J., Guan, L. L., Yao, J., & Wu, S. (2024) · Microbiome · doi:10.1186/s40168-024-01964-0 · Cited by 33
Zhang, Q.-Q., Zhang, W.-J., & Chang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168848 · Cited by 24
Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome
Yan, H., Li, B., Su, R. J., Gao, C., Li, X., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873644 · Cited by 24
Brown, M. E., Peters, L. D., Hanbali, S., Arnoletti, J. M., Sachs, L. K., Nguyen, K. Q., Carpenter, E. B., Seay, H. R., Fuhrman, C. A., Posgai, A. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873560 · Cited by 25
“As a result, the CD4CD25CD127 population is predisposed to an outgrowth of less suppressive Tregs and increased expression of inflammatory/effector molecules during expansion, all of which may negatively impact ACT therapeutic efficacy (29).”
BackgroundRoles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
Matsuda, M., Terada, T., Kitatani, K., Kawata, R., & Nabe, T. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.981126 · Cited by 24
Sun, N., Wang, C., Edwards, W., Wang, Y., Lu, X. L., Gu, C., McLennan, S., Shangaris, P., Peng, Q., Mastronicola, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202416066 · Cited by 24
Self-citationLi, X., Xu, H., Huang, J., Luo, D., Lv, S., Lu, X., & Xiao, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716081 · Cited by 47
Headen, K., Jakaitė, V., Mesarič, V. A., Scottà, C., Lombardi, G., Nicolaides, K. H., & Shangaris, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094884 · Cited by 21
Self-citationMany Faces of Regulatory T Cells: Heterogeneity or Plasticity?
Blinova, V. G., & Zhdanov, D. D. (2024) · Cells · doi:10.3390/cells13110959 · Cited by 20
Fanelli, G., Marks, P., Aiyengar, A., Romano, M., Gooljar, S. B., Kumar, S., Burch, M., & Lombardi, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06561-9 · Cited by 17
“Over the past years, the success of Treg transfer in pre-clinical animal models of GvHD, solid organ transplantation and autoimmune diseases has laid the foundations for several early-stage clinical trials aiming to investigate the safety and biological impact of adaptive Treg therapy [1–3].”
Tissue adaptation of regulatory T cells in adipose tissue
Yu, Y.-M., Bai, H.-Y., Wu, F.-L., Chen, J.-Q., Li, B., & Li, Y.-Y. (2022) · European Journal of Immunology · doi:10.1002/eji.202149527 · Cited by 15
Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
Liu, Y., Tu, M., & Wang, L. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s354195 · Cited by 16
“As we know, the most influential immune cells in the TME are the tumor associatedmacrophages (TAMs) and Treg cells.(34,36) These immune cells have diverse functions in cancer development and progression.”
BackgroundExpression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells
Osborne, D. G., Domenico, J. M., & Fujita, M. (2022) · Cells · doi:10.3390/cells11162565 · Cited by 16
“While novel genome editing techniques and the identification of stable Treg markers, such as GPA33, have improved the efficacy of modifying primary Treg cells [4,5], experimental challenges still exist due to many factors, including the inter-personal and intra-personal heterogeneity of primary human Treg cells [4].”
BackgroundStroukov, W., Mastronicola, D., Albany, C. J., Catak, Z., Lombardi, G., & Scottà, C. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24720 · Cited by 14
“The level of expression of these two molecules can be used to identify the three functional subsets described by Miyara and collaborators: naïve (population I, CD45RA CD25), effector (population II, CD45RA CD25) and cytokine-producing (population III, CD45RA CD25) Treg cells [3, 27].”
BackgroundSelf-citationBandaru, S. S., Boyilla, R., Merchant, N., Nagaraju, G. P., & El‐Rayes, B. F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106197 · Cited by 15
Wu, W., Chen, L., Jia, G., Tang, Q., Han, B., Xia, S., Jiang, Q., & Liu, H. (2023) · Cancer Medicine · doi:10.1002/cam4.6172 · Cited by 13
The dynamics of Th17 / Treg ratio in SLE patients during pregnancy
Braga, A. C., Neves, E., Guimarães, J., Braga, J. S., & Vasconcelos, C. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103622 · Cited by 14
Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy
Gao, Y.-L., Liu, Y.-C., Zhang, X., Shou, S.-T., & Chai, Y.-F. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.830784 · Cited by 11
Determining role of thymus in immune pathogenesis of autoimmune, oncological and infectious diseases
Va, K. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-dro-2591 · Cited by 11
Hall, B. M., Hall, R. M., Tran, G. T., Robinson, C. M., Wilcox, P. L., Rakesh, P., Wang, C., Sharland, A. F., Verma, N. D., & Hodgkinson, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714838 · Cited by 12
Zhao, Y., Zheng, X., Li, M., Zhao, J., Wang, X., & Zhu, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109620 · Cited by 11
Zhang, L., Xu, Z., Li, Y., Wu, K., Yu, C., Zhu, W., Sun, D., Zhu, L., & Zhou, J. (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102044 · Cited by 10
Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer
Aghabi, Y., Yasin, A., KENNEDY, J., Davies, S. P., Butler, A. E., & Stamataki, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662134 · Cited by 11
Regulatory TR3-56 Cells in the Complex Panorama of Immune Activation and Regulation
Carriero, F., Rubino, V., Leone, S., Montanaro, R., Brancaleone, V., Ruggiero, G., & Terrazzano, G. (2023) · Cells · doi:10.3390/cells12242841 · Cited by 12
“Strategies include Treg-based cellular therapies and the modulation of Treg function and stability for therapeutic interventions [66,67].”
BackgroundThe frequency of Treg subsets distinguishes disease activity in ANCA vasculitis
Agosto‐Burgos, C., Wu, E. Y., Iannone, M. A., Hu, Y., Hogan, S. L., Henderson, C. D., Kennedy, K. B., Blazek, L. N., Herrera, C. A., Munson, D., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1428 · Cited by 9
Pham, M. N., Khoryati, L., Jamison, B. L., Hayes, E. T., Sullivan, J. M., Campbell, D., & Gavin, M. A. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100051 · Cited by 11
Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?
Matarneh, A. S., Patel, M. A., Parikh, K., Karasinski, A. A., Kaur, G., Shah, V. H., Ghahramani, N., & Trivedi, N. (2025) · Antibodies · doi:10.3390/antib14020049 · Cited by 13
Tauber, P. A., Kratzer, B., Schatzlmaier, P., Smole, U., Köhler, C., Rausch, L., Kranich, J., Trapin, D., Neunkirchner, A., Zabel, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1094694 · Cited by 9
Sérazin, C., Dugast, L., Flippe, L., Streitz, M., Wendering, D. J., Schlickeiser, S., Heinrich, F., Durek, P., Guerra, G. M., Lehmann, K., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113512 · Cited by 7
Bi, Y., Kong, R., Peng, Y., Cai, D., Zhang, Y., Yang, F., Li, X., Deng, W., Liu, F., He, B., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01277-0 · Cited by 6
Chmiel, J., Stasiak, M., Skrzypkowska, M. W., Samson, L., Łuczkiewicz, P., & Trzonkowski, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36512 · Cited by 6
“All these Tregs subsets and their specific properties can be exploited to develop novel treatment methods [69].”
BackgroundGM-CSF-dependent CD301b+ mouse lung dendritic cells confer tolerance to inhaled allergens
Wilkinson, C. L., Nakano, K., Grimm, S. A., Whitehead, G. S., Arao, Y., Blackshear, P. J., Karmaus, P. W. F., Fessler, M. B., Cook, D. N., & Nakano, H. (2025) · Nature Communications · doi:10.1038/s41467-025-63547-3 · Cited by 7
Bi, Y., Kong, R., Peng, Y., Yu, H., & Zhou, Z. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109716 · Cited by 7
Yao, M., Chen, H., Chen, Z., Wang, Y., Shi, D., Wu, D., Li, W., Huang, J., Chen, G.-Z., Zheng, Q., et al. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae026 · Cited by 6
Huang, H., Li, M., Song, S., Feng, S., Feng, X., Liu, Y., Yang, P., & Zheng, P. (2025) · Scientific Reports · doi:10.1038/s41598-024-84079-8 · Cited by 5
“In subjects with allergic diseases, it has been attempted to restore immune regulatory functions through the use of probiotics, curcumin, or adoptive transfer of Treg cells 7 .”
Liu, Y., Hoang, T. K., Park, E. S., Freeborn, J., Okeugo, B., Tran, D. Q., & Rhoads, J. M. (2023) · Beneficial Microbes · doi:10.3920/bm2022.0095 · Cited by 5
Wang, Y., Jia, Y., Guo, H., Feng, M., Qin, Y., Liang, Z., Zhao, X., Gao, C., & Luo, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603305 · Cited by 6
“However, studies on the heterogeneity of Treg cell subsets have revealed distinct subpopulations with different functions in controlling the immune response and inducing peripheral tolerance (29).”
Arroyo-Olarte, R. D., Pérez-Noriega, F. A., Correa-Pérez, M. F., Mejía-Muñoz, A., Terrazas, L. I., & León‐Cabrera, S. (2025) · Immunologic Research · doi:10.1007/s12026-025-09686-7 · Cited by 6
“There is significant variability among Tregs in terms of their development, antigen specificity, activation status, and responses to inflammation [15, 16].”
Chai, W.-H., Ma, Y., Li, J.-J., Guo, F., Wu, Y.-Z., & Liu, J.-W. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i17.3094 · Cited by 5
“CD4+CD25highCD127Low/−FOXP3+ regulatory T cells are pivotal in preserving immune tolerance and curbing excessive immune reactions[40].”
CD4+CD25+ regulatory T cell therapy in neurological autoimmune diseases
Yuan, G., Liu, Y., Wang, H., Yang, T., & Liu, G.-Z. (2025) · PeerJ · doi:10.7717/peerj.19450 · Cited by 3
“…clinical trials have demonstrated the favorable safety profile of allogeneic Treg therapy, concerns regarding immune-mediated rejection and limited cell survival necessitate the prioritization of autologous Treg therapy in current clinical practice ( Hennessy et al., 2023 ; Giganti et al., 2021 ).”
Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory Cells
Krause, N., Mengwasser, J., Phithak, E., Beato, F., Appis, M. L., Milford, E. L., Pratschke, J., Sauer, I. M., Kuehl, A. A., Vogel, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790775 · Cited by 4
Dou, H., Brandon, N. R., Koper, K., & Xu, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00397 · Cited by 3
“37,38 The specific function of T reg after cardiac arrest is unclear, but since CD4 + CD25 + T reg cells play a central role in systemic immune tolerance and immune suppression, the expansion of CD4 + CD25 + cells in the blood may indicate CAR-induced systemic immune suppression in response to…”
Kildyushevsky, A. V., Moysyuk, Y. G., Mitina, T. A., Кофиади, И. А., & Chuksina, Y. Y. (2022) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2022-14-2-195-209 · Cited by 2
“Дальнейшие исследования гетерогенности популяции Treg-клеток выявили различные субпопуляции с различными функциями в контроле иммунного ответа и индукции периферической толерантности [84].”
Lin, M., Li, W. X., Wu, Y., Li, M., Li, Y., & Zhao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776040 · Cited by 3
“Concurrently, novel therapeutic targets, such as CD74 blockade, which target the migrasome-APP-CD74 axis, offer new translational directions for mitigating vascular in fl ammation (83, 86).”
Sato, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1762753 · Cited by 2
“Nevertheless, their clinical application is constrained by incomplete knowledge of disease-relevant antigens, antigen heterogeneity, and epitope spreading in complex immune-mediated disorders (61).”
When There Is No Need for Immunosupresives: Combined Bone Marrow and Kidney Transplantation
Herenda, V., Rebić, D., Hamzić-Mehmedbašić, A., Ribić-Mrkonja, A., & Odobašić, M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006524 · Cited by 2
Jin, L., Fu, J., Lin, X., Jin, L., Guo, Y., Liu, X., Khalifa, S. A. M., El-Seedi, H. R., Fu, H., & Shou, Q. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106573 · Cited by 1
Tran, G. T., Bedi, S., Rakesh, P., Verma, N. D., Carter, N., Robinson, C. M., Al-Atiyah, R., Hall, B. M., & Hodgkinson, S. J. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578611 · Cited by 1
Albany, C. J., Mastronicola, D., Popov, M., Stroukov, W., Wierzbicki, A. S., Martínez-Nuñez, R. T., Lombardi, G., & Scottà, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1662925 · Cited by 1
“Tregs modulate both innate and adaptive immune responses by suppressing in fl ammatory cells (12).”
InfluentialSelf-citationBraileanu, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648926 · Cited by 2
TIM3-mediated differentiation of IL-10-producing CD25+ B cells by expanded regulatory T cells
Alhabbab, R. Y., Mastronicola, D., Lombardi, G., & Scottà, C. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02606-0 · Cited by 1
“Several phase I/II clinical trials have been conducted with promising results, some still ongoing [5], while others have been completed and shown some biological efficacy [6, 7].”
Self-citationTripathi, S., Julé, A. M., Zhu, Z., Schreiber, B., Martín-Moreno, P. L., Sui, S. H., Waaga-Gasser, A. M., & Chandraker, A. K. (2026) · Scientific Reports · doi:10.1038/s41598-025-33656-6 · Cited by 1
“These findings highlight the importance of understanding Treg heterogeneity in the context of developing effective cell-based therapies 11 .”
Cobb, J., Rawson, J., Gonzalez, N. N., Kandeel, F., & Husseiny, M. I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1740385 · Cited by 1
Future-directed studies on immunosuppressive treatments and xenografts for organ transplantation
Park, J.-I., & Jung, B. H. (2022) · Annals of Liver Transplantation · doi:10.52604/alt.22.0003 · Cited by 1
Jiang, S., Zhu, L., Xu, Y., Liu, Z., Cai, J., Zhu, T., Fan, Q., & Zhao, Z. (2024) · Endocrine · doi:10.1007/s12020-024-03932-y · Cited by 1
“Treg cells, as a subpopulation of T cells, are well known to be present in areas of allografts and xenografts [36, 37].”
Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy
Tan, H., Su, W., & Niu, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125390 · Cited by 1
“…tissue microenvironmental balance by suppressing excessive immune responses and can migrate across the BBB into CNS. Activation of nicotinic acetylcholine receptors on their surface promotes clonal expansion within the hippocampus and modulates neuroinflammation via acetylcholine signaling [33,34].”
Radiation Triggered Phenotypic Changes of Regulatory T Cells
Liu, L., Peng, Y., Zhang, D., & Niu, D. (2022) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2022.118.128
“Treg cell treatment in pre-clinical animal models showed the enormous therapeutic potential of these cells in immune-mediated diseases and placed the foundations for their applications in therapy in humans (Giganti et al., 2021).”
BackgroundPovoleri, G. A. M., Fleskens, V., & Taams, L. S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_13
Self-citationThe Concept of Infection-Triggered Autoimmunity
Guarneri, F. (2022) · Springer eBooks · doi:10.1007/978-981-19-1946-6_1
EXPANSION OF ANTIGEN- SPECIFIC MEMORY CELLS AS A POTENTIAL BOOSTER FOR FOOD TOLERANCE INDUCTIONPreprint
Silva, A. P. E., Marmello, B. O., Bentes, A. L., Faccini, C. R. J. D. N., Rodrigues, S. K. P. M., Soares, J. R. A., Campos, S. M. N., & Teixeira, G. A. P. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.526302
“CD4+CD25+Foxp3high regulatory T lymphocytes, also called thymic regulatory T cells [67], in”
BackgroundSérazin, C., Flippe, L., Streitz, M., Wendering, D. J., Schlickeiser, S., Heinrich, F., Durek, P., Guerra, G. M., Lehmann, K., Mashreghi, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.13.571475 · Cited by 2
“…for which studies on heterogeneity revealed distinct subsets 49 with different functions playing a particular role in different pathologic situations 50 , it is highly probable that there are several populations of CD8 + Tregs with specific properties and playing a role in different situations.”
BackgroundAtif, M. (2021) · theses.fr (ABES) · doi:10.70675/d1c1d2a9z5be5z42a1z9bb6z1a4f3437244e
Self-citationRole of regulatory T cells in pathogenesis and therapeutics of Hashimoto’s thyroiditis
Asadollahzadeh, E., Ebadi, Z., Hamed, Z., & Moghadasi, A. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13947-5.00005-1
Bioinformatics analysis of the role of lysosome-related genes in breast cancer
Wang, Z., Tang, R., Wang, H., Li, X., Liu, Z., Li, W., Gui, P., & Zhou, H. (2024) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2024.2379936
“Treg cells are critical for maintaining immune tolerance and avoiding excessive immune responses (Giganti et al. 2021).”
Yuan, C., Shu, X., Wang, X., Hu, Z., & Jie, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-04250-z
“CD25 and Foxp3 serve as specific markers for Tregs and are crucial for their immunosuppressive activity [6, 7].”
Evaluation of TIRC7 expression in human T regulatory cells
Krause, N. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-46383
Ho, Q. Y., Hashimoto, H., Hester, J., & Issa, F. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201667
“17,18 22 In conventional FACS sorters, cells are hy-drodynamically focused, then separated into discrete droplets by passing the fluid stream through a vibrating nozzle.”
Huang, J.-C., Zhao, Y., Han, Y., Xia, Z., Du, G., Lang, R., & Zhou, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1829051
“The coexistence of increased CD4 + Foxp3 + Tregs and CD8 + CD45RC low/- Tregs highlights the complexity of immune regulation in transplantation, in which multiple regulatory may act in parallel or cooperatively to maintain tolerance (20).”
A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus
Renaudineau, Y., Hedrich, C. M., Guéry, J., Miyara, M., Damoiseaux, J. G. M. C., Mouthon, L., Pugnet, G., Faguer, S., Delpuech, A., Bellière, J., et al. (2026) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2026.100379
“…in Treg therapies lies in the capacity to generate sufficient quantities of stable and functional Tregs ex vivo , which may be addressed through the development of autologous chimeric antigen receptor (CAR)-Tregs or through autologous eTreg expansion in combinations with small-molecule drugs [41].”
Self-citationUrsavaş, S., Canbaz, H. T., Ay, E. N., Demirci, H., Pasin, Ö., Şekerci, A., Senol, E. Y., & Karaöz, E. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102953
Al‐Basri, A. K., Sedighi, S., Bagheri, Y., Jazi, M. S., Heydari, E., Azimi, H., & Davoodi, H. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70803
“IL-10, produced by TH2 lymphocytes, T regulatory cells, and macrophages, is an anti-inflammatory factor [12].”
Assessment of CD3/PD-L1-mediated regulatory T cell induction in vitro
Ponomareva, V. N. (2026) · Russian Journal of Immunology · doi:10.46235/1028-7221-17416-aoc
Metadata
- Authors
- Giganti, G., Atif, M., Mohseni, Y., Mastronicola, D., Grageda, N., Povoleri, G. A., Miyara, M., & Scottà, C.
- Affiliations
- King's College London (GB)
- Inserm (FR)
- Corresponding author
- Scottà, Cristiano
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2020-12-23
- Volume
- 51
- Issue
- 1
- Pages
- 39-55
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W3107023216
- Cited by
- 82
- References
- 133
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 19 · 2023: 16 · 2022: 19 · 2021: 5 · 2020: 1
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.scopus.com
- Licence
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- regulatory T cells, Treg subsets, immune tolerance, autoimmune disease, allogeneic hematopoietic stem cell transplantation, solid organ transplantation
- MeSH terms
- Adipose Tissue, Animals, Autoimmune Diseases, Humans, Immune Tolerance, Transplantation Immunology, Wound Healing, Immunotherapy, Adoptive, Hematopoietic Stem Cell Transplantation, Models, Immunological, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Peripheral Tolerance, Allografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.